{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T12:22:31Z","timestamp":1784550151787,"version":"3.55.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,2,6]],"date-time":"2024-02-06T00:00:00Z","timestamp":1707177600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,2,6]],"date-time":"2024-02-06T00:00:00Z","timestamp":1707177600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","award":["Unrestricted Research Grant number 5714134"],"award-info":[{"award-number":["Unrestricted Research Grant number 5714134"]}],"id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"DOI":"10.1007\/s00296-024-05536-1","type":"journal-article","created":{"date-parts":[[2024,2,6]],"date-time":"2024-02-06T17:34:42Z","timestamp":1707240882000},"page":"675-685","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Exploring 5-year changes in general and skin health-related quality of life in psoriatic arthritis patients"],"prefix":"10.1007","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7967-0880","authenticated-orcid":false,"given":"Mateusz","family":"Wilk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0103-2840","authenticated-orcid":false,"given":"Brigitte","family":"Michelsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2801-6584","authenticated-orcid":false,"given":"Katarzyna","family":"\u0141osi\u0144ska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6942-5830","authenticated-orcid":false,"given":"Arthur","family":"Kavanaugh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1749-9739","authenticated-orcid":false,"given":"Mariusz","family":"Korkosz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9279-5191","authenticated-orcid":false,"given":"Glenn","family":"Haugeberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,2,6]]},"reference":[{"key":"5536_CR1","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1136\/ANNRHEUMDIS-2013-203862","volume":"74","author":"M Hoff","year":"2015","unstructured":"Hoff M, Gulati AM, Romundstad PR et al (2015) Prevalence and incidence rates of psoriatic arthritis in central Norway: data from the Nord-Tr\u00f8ndelag health study (HUNT). Ann Rheum Dis 74:60\u201364. https:\/\/doi.org\/10.1136\/ANNRHEUMDIS-2013-203862","journal-title":"Ann Rheum Dis"},{"key":"5536_CR2","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1080\/03009742.2021.1997436","volume":"52","author":"AM Kerola","year":"2023","unstructured":"Kerola AM, Rollefstad S, Kazemi A et al (2023) Psoriatic arthritis, axial spondyloarthritis and rheumatoid arthritis in Norway: nationwide prevalence and use of biologic agents. Scand J Rheumatol 52:42\u201350. https:\/\/doi.org\/10.1080\/03009742.2021.1997436","journal-title":"Scand J Rheumatol"},{"key":"5536_CR3","doi-asserted-by":"publisher","DOI":"10.3899\/JRHEUM.220310","author":"CB Campanholo","year":"2022","unstructured":"Campanholo CB, Maharaj AB, Corp N et al (2022) Management of psoriatic arthritis in patients with comorbidities: an updated literature review informing the 2021 GRAPPA treatment recommendations. J Rheumatol jrheum. https:\/\/doi.org\/10.3899\/JRHEUM.220310","journal-title":"J Rheumatol jrheum"},{"key":"5536_CR4","first-page":"680","volume":"35","author":"S Lee","year":"2010","unstructured":"Lee S, Mendelsohn A, Sarnes E (2010) The burden of psoriatic arthritis: a literature review from a global health systems perspective. Pharmacy and Therapeutics 35:680","journal-title":"Pharmacy and Therapeutics"},{"key":"5536_CR5","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/S00296-018-4195-X\/TABLES\/2","volume":"39","author":"A Gottlieb","year":"2019","unstructured":"Gottlieb A, Gratacos J, Dikranian A et al (2019) Treatment patterns, unmet need, and impact on patient-reported outcomes of psoriatic arthritis in the United States and Europe. Rheumatol Int 39:121\u2013130. https:\/\/doi.org\/10.1007\/S00296-018-4195-X\/TABLES\/2","journal-title":"Rheumatol Int"},{"key":"5536_CR6","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1136\/ANNRHEUMDIS-2018-213286","volume":"77","author":"B Michelsen","year":"2018","unstructured":"Michelsen B, Uhlig T, Sexton J et al (2018) Health-related quality of life in patients with psoriatic and rheumatoid arthritis: data from the prospective multicentre NOR-DMARD study compared with Norwegian general population controls. Ann Rheum Dis 77:1290\u20131294. https:\/\/doi.org\/10.1136\/ANNRHEUMDIS-2018-213286","journal-title":"Ann Rheum Dis"},{"key":"5536_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/S13075-018-1659-Z","author":"G Haugeberg","year":"2018","unstructured":"Haugeberg G, Michelsen B, Tengesdal S et al (2018) Ten years of follow-up data in psoriatic arthritis: results based on standardized monitoring of patients in an ordinary outpatient clinic in southern Norway. Arthritis Res Ther. https:\/\/doi.org\/10.1186\/S13075-018-1659-Z","journal-title":"Arthritis Res Ther"},{"key":"5536_CR8","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1136\/ANNRHEUMDIS-2018-215003","volume":"78","author":"A Kavanaugh","year":"2019","unstructured":"Kavanaugh A, Gottlieb A, Morita A et al (2019) The contribution of joint and skin improvements to the health-related quality of life of patients with psoriatic arthritis: a post hoc analysis of two randomised controlled studies. Ann Rheum Dis 78:1215\u20131219. https:\/\/doi.org\/10.1136\/ANNRHEUMDIS-2018-215003","journal-title":"Ann Rheum Dis"},{"key":"5536_CR9","doi-asserted-by":"publisher","DOI":"10.1136\/RMDOPEN-2020-001223","author":"G Haugeberg","year":"2020","unstructured":"Haugeberg G, Michelsen B, Kavanaugh A (2020) Impact of skin, musculoskeletal and psychosocial aspects on quality of life in psoriatic arthritis patients: a cross-sectional study of outpatient clinic patients in the biologic treatment era. RMD Open. https:\/\/doi.org\/10.1136\/RMDOPEN-2020-001223","journal-title":"RMD Open"},{"key":"5536_CR10","doi-asserted-by":"publisher","first-page":"2665","DOI":"10.1002\/ART.21972","volume":"54","author":"W Taylor","year":"2006","unstructured":"Taylor W, Gladman D, Helliwell P et al (2006) Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum 54:2665\u20132673. https:\/\/doi.org\/10.1002\/ART.21972","journal-title":"Arthritis Rheum"},{"key":"5536_CR11","doi-asserted-by":"publisher","first-page":"431","DOI":"10.3899\/JRHEUM.160973","volume":"44","author":"B Michelsen","year":"2017","unstructured":"Michelsen B, Diamantopoulos AP, H\u00f8iberg HK et al (2017) Need for improvement in current treatment of psoriatic arthritis: study of an outpatient clinic population. J Rheumatol 44:431\u2013436. https:\/\/doi.org\/10.3899\/JRHEUM.160973","journal-title":"J Rheumatol"},{"key":"5536_CR12","doi-asserted-by":"publisher","DOI":"10.1080\/03009742.2023.2247703","author":"K \u0141osi\u0144ska","year":"2023","unstructured":"\u0141osi\u0144ska K, Michelsen B, Kavanaugh A et al (2023) Psoriatic arthritis: improvement in outcomes but persistent sex difference - 5-year follow-up study of a Norwegian outpatient clinic population. Scand J Rheumatol. https:\/\/doi.org\/10.1080\/03009742.2023.2247703","journal-title":"Scand J Rheumatol"},{"key":"5536_CR13","first-page":"91","volume":"34","author":"T Sokka","year":"2016","unstructured":"Sokka T (2016) Go, go, GoTreatIT! Clin Exp Rheumatol 34:91\u201395","journal-title":"Clin Exp Rheumatol"},{"key":"5536_CR14","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1136\/ARD.2009.122259","volume":"69","author":"M Schoels","year":"2010","unstructured":"Schoels M, Aletaha D, Funovits J et al (2010) Application of the DAREA\/DAPSA score for assessment of disease activity in psoriatic arthritis. Ann Rheum Dis 69:1441\u20131447. https:\/\/doi.org\/10.1136\/ARD.2009.122259","journal-title":"Ann Rheum Dis"},{"key":"5536_CR15","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1002\/ART.1780261107","volume":"26","author":"T Pincus","year":"1983","unstructured":"Pincus T, Summey JA, Soraci SA et al (1983) Assessment of patient satisfaction in activities of daily living using a modified Stanford Health Assessment Questionnaire. Arthritis Rheum 26:1346\u20131353. https:\/\/doi.org\/10.1002\/ART.1780261107","journal-title":"Arthritis Rheum"},{"key":"5536_CR16","doi-asserted-by":"publisher","first-page":"2220","DOI":"10.1002\/1529-0131","volume":"42","author":"T Pincus","year":"1999","unstructured":"Pincus T, Swearingen C, Wolfe F (1999) Toward a multidimensional health assessment questionnaire (MDHAQ) assessment of advanced activities of daily living and psychological status in the patient-friendly health assessment questionnaire format. Arthritis Rheum 42:2220\u20132230. https:\/\/doi.org\/10.1002\/1529-0131","journal-title":"Arthritis Rheum"},{"key":"5536_CR17","doi-asserted-by":"publisher","first-page":"328","DOI":"10.3109\/07853890109002086","volume":"33","author":"H Sintonen","year":"2001","unstructured":"Sintonen H (2001) The 15D instrument of health-related quality of life: properties and applications. Ann Med 33:328\u2013336. https:\/\/doi.org\/10.3109\/07853890109002086","journal-title":"Ann Med"},{"key":"5536_CR18","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1007\/S11136-006-0020-1","volume":"15","author":"SI Saarni","year":"2006","unstructured":"Saarni SI, H\u00e4rk\u00e4nen T, Sintonen H et al (2006) The impact of 29 chronic conditions on health-related quality of life: a general population survey in Finland using 15D and EQ-5D. Qual Life Res 15:1403\u20131414. https:\/\/doi.org\/10.1007\/S11136-006-0020-1","journal-title":"Qual Life Res"},{"key":"5536_CR19","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1111\/J.1365-2230.1994.TB01167.X","volume":"19","author":"AY Finlay","year":"1994","unstructured":"Finlay AY, Khan GK (1994) Dermatology Life Quality Index (DLQI)\u2013a simple practical measure for routine clinical use. Clin Exp Dermatol 19:210\u2013216. https:\/\/doi.org\/10.1111\/J.1365-2230.1994.TB01167.X","journal-title":"Clin Exp Dermatol"},{"key":"5536_CR20","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/S40744-016-0029-Z","volume":"3","author":"A Kavanaugh","year":"2016","unstructured":"Kavanaugh A, Helliwell P, Ritchlin CT (2016) Psoriatic arthritis and burden of disease: patient perspectives from the population-based Multinational Assessment of Psoriasis and Psoriatic Arthritis (MAPP) Survey. Rheumatol Ther 3:91\u2013102. https:\/\/doi.org\/10.1007\/S40744-016-0029-Z","journal-title":"Rheumatol Ther"},{"key":"5536_CR21","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1007\/S00296-016-3514-3\/TABLES\/6","volume":"36","author":"P Kawalec","year":"2016","unstructured":"Kawalec P, Malinowski KP, Pilc A (2016) Disease activity, quality of life and indirect costs of psoriatic arthritis in Poland. Rheumatol Int 36:1223\u20131230. https:\/\/doi.org\/10.1007\/S00296-016-3514-3\/TABLES\/6","journal-title":"Rheumatol Int"},{"key":"5536_CR22","doi-asserted-by":"publisher","first-page":"4061","DOI":"10.1007\/S10067-021-05713-8","volume":"40","author":"JF Merola","year":"2021","unstructured":"Merola JF, Dennis N, Chakravarty SD et al (2021) Healthcare utilization and costs among patients with psoriasis and psoriatic arthritis in the USA-a retrospective study of claims data from 2009 to 2020. Clin Rheumatol 40:4061\u20134070. https:\/\/doi.org\/10.1007\/S10067-021-05713-8","journal-title":"Clin Rheumatol"},{"key":"5536_CR23","first-page":"1842","volume":"28","author":"KB Sokoll","year":"2001","unstructured":"Sokoll KB, Helliwell PS (2001) Comparison of disability and quality of life in rheumatoid and psoriatic arthritis. J Rheumatol 28:1842\u20131846","journal-title":"J Rheumatol"},{"key":"5536_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7525-7-25","author":"F Salaffi","year":"2009","unstructured":"Salaffi F, Carotti M, Gasparini S et al (2009) The health-related quality of life in rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis: a comparison with a selected sample of healthy people. Health Qual Life Outcomes. https:\/\/doi.org\/10.1186\/1477-7525-7-25","journal-title":"Health Qual Life Outcomes"},{"key":"5536_CR25","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1007\/S00296-021-05070-4","volume":"42","author":"M Wilk","year":"2022","unstructured":"Wilk M, \u0141osi\u0144ska K, Pripp AH et al (2022) Pain catastrophizing in rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis: biopsychosocial perspective and impact on health-related quality of life. Rheumatol Int 42:669\u2013682. https:\/\/doi.org\/10.1007\/S00296-021-05070-4","journal-title":"Rheumatol Int"},{"key":"5536_CR26","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.3899\/jrheum.160904","volume":"44","author":"AM Orbai","year":"2017","unstructured":"Orbai AM, De Wit M, Mease PJ et al (2017) Updating the psoriatic arthritis (PsA) core domain set: a report from the PsA workshop at OMERACT 2016. J Rheumatol 44:1522\u20131528. https:\/\/doi.org\/10.3899\/jrheum.160904","journal-title":"J Rheumatol"},{"key":"5536_CR27","doi-asserted-by":"publisher","first-page":"46","DOI":"10.3899\/JRHEUM.200127","volume":"96","author":"YY Leung","year":"2020","unstructured":"Leung YY, Tillett W, Orbai AM et al (2020) The GRAPPA-OMERACT Working Group: 4 prioritized domains for completing the core outcome measurement set for psoriatic arthritis 2019 updates. J Rheumatol Suppl 96:46\u201349. https:\/\/doi.org\/10.3899\/JRHEUM.200127","journal-title":"J Rheumatol Suppl"},{"key":"5536_CR28","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1111\/J.1365-2133.2006.07405.X","volume":"155","author":"L Dubertret","year":"2006","unstructured":"Dubertret L, Mrowietz U, Ranki A et al (2006) European patient perspectives on the impact of psoriasis: the EUROPSO patient membership survey. Br J Dermatol 155:729\u2013736. https:\/\/doi.org\/10.1111\/J.1365-2133.2006.07405.X","journal-title":"Br J Dermatol"},{"key":"5536_CR29","doi-asserted-by":"publisher","first-page":"e390","DOI":"10.1016\/S2665-9913(22)00101-1","volume":"4","author":"LC Coates","year":"2022","unstructured":"Coates LC, O\u2019Dwyer J, Meads D et al (2022) Treat-to-target in psoriatic arthritis\u2014cost-effective in the biosimilar era. Lancet Rheumatol 4:e390\u2013e391. https:\/\/doi.org\/10.1016\/S2665-9913(22)00101-1","journal-title":"Lancet Rheumatol"},{"key":"5536_CR30","doi-asserted-by":"publisher","DOI":"10.1136\/BMJOPEN-2021-058497","volume":"12","author":"Y Lu","year":"2022","unstructured":"Lu Y, Dai Z, Lu Y, Chang F (2022) Effects of bDMARDs on quality of life in patients with psoriatic arthritis: meta-analysis. BMJ Open 12:e058497. https:\/\/doi.org\/10.1136\/BMJOPEN-2021-058497","journal-title":"BMJ Open"},{"key":"5536_CR31","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/S00296-020-04775-2","volume":"41","author":"S Gupta","year":"2021","unstructured":"Gupta S, Syrimi Z, Hughes DM, Zhao SS (2021) Comorbidities in psoriatic arthritis: a systematic review and meta-analysis. Rheumatol Int 41:275. https:\/\/doi.org\/10.1007\/S00296-020-04775-2","journal-title":"Rheumatol Int"},{"key":"5536_CR32","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/S00296-016-3487-2\/METRICS","volume":"37","author":"KM Yim","year":"2017","unstructured":"Yim KM, Armstrong AW (2017) Updates on cardiovascular comorbidities associated with psoriatic diseases: epidemiology and mechanisms. Rheumatol Int 37:97\u2013105. https:\/\/doi.org\/10.1007\/S00296-016-3487-2\/METRICS","journal-title":"Rheumatol Int"},{"key":"5536_CR33","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/S00296-017-3895-Y\/METRICS","volume":"38","author":"P Patel","year":"2018","unstructured":"Patel P, Rosen CF, Chandran V et al (2018) Addressing comorbidities in psoriatic disease. Rheumatol Int 38:219\u2013227. https:\/\/doi.org\/10.1007\/S00296-017-3895-Y\/METRICS","journal-title":"Rheumatol Int"},{"key":"5536_CR34","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1177\/1759720X15591801","volume":"7","author":"L Eder","year":"2015","unstructured":"Eder L, Gladman DD (2015) Atherosclerosis in psoriatic disease: latest evidence and clinical implications. Ther Adv Musculoskelet Dis 7:187. https:\/\/doi.org\/10.1177\/1759720X15591801","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"5536_CR35","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1007\/S00296-015-3228-Y\/METRICS","volume":"35","author":"B Yilmazer","year":"2015","unstructured":"Yilmazer B, Sahin T, Unlu B\u00d6 et al (2015) Investigation of subclinical atherosclerosis in psoriatic arthritis patients with minimal disease activity. Rheumatol Int 35:1385\u20131392. https:\/\/doi.org\/10.1007\/S00296-015-3228-Y\/METRICS","journal-title":"Rheumatol Int"},{"key":"5536_CR36","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/S00296-016-3617-X\/METRICS","volume":"37","author":"R Ib\u00e1\u00f1ez-Bosch","year":"2017","unstructured":"Ib\u00e1\u00f1ez-Bosch R, Restrepo-Velez J, Medina-Malone M et al (2017) High prevalence of subclinical atherosclerosis in psoriatic arthritis patients: a study based on carotid ultrasound. Rheumatol Int 37:107\u2013112. https:\/\/doi.org\/10.1007\/S00296-016-3617-X\/METRICS","journal-title":"Rheumatol Int"},{"key":"5536_CR37","doi-asserted-by":"publisher","first-page":"128","DOI":"10.3899\/JRHEUM.210963","volume":"49","author":"YY Leung","year":"2022","unstructured":"Leung YY (2022) Is psoriatic arthritis associated with higher risk of mortality? J Rheumatol 49:128\u2013131. https:\/\/doi.org\/10.3899\/JRHEUM.210963","journal-title":"J Rheumatol"},{"key":"5536_CR38","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1136\/ANNRHEUMDIS-2011-201194","volume":"72","author":"A Jamnitski","year":"2013","unstructured":"Jamnitski A, Symmons D, Peters MJL et al (2013) Cardiovascular comorbidities in patients with psoriatic arthritis: a systematic review. Ann Rheum Dis 72:211\u2013216. https:\/\/doi.org\/10.1136\/ANNRHEUMDIS-2011-201194","journal-title":"Ann Rheum Dis"},{"key":"5536_CR39","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1111\/BJD.12670","volume":"170","author":"AW Armstrong","year":"2014","unstructured":"Armstrong AW, Harskamp CT, Dhillon JS, Armstrong EJ (2014) Psoriasis and smoking: a systematic review and meta-analysis. Br J Dermatol 170:304\u2013314. https:\/\/doi.org\/10.1111\/BJD.12670","journal-title":"Br J Dermatol"},{"key":"5536_CR40","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1001\/JAMADERMATOL.2020.0024","volume":"156","author":"S Vaengebjerg","year":"2020","unstructured":"Vaengebjerg S, Skov L, Egeberg A, Loft ND (2020) Prevalence, incidence, and risk of cancer in patients with psoriasis and psoriatic arthritis: a systematic review and meta-analysis. JAMA Dermatol 156:421\u2013429. https:\/\/doi.org\/10.1001\/JAMADERMATOL.2020.0024","journal-title":"JAMA Dermatol"},{"key":"5536_CR41","doi-asserted-by":"publisher","DOI":"10.1177\/1759720X221122417\/ASSET\/IMAGES\/LARGE\/10.1177_1759720X221122417-FIG1.JPEG","author":"CG Gialouri","year":"2022","unstructured":"Gialouri CG, Evangelatos G, Pappa M et al (2022) Normal C-reactive protein in active psoriatic arthritis: results from real-world clinical practice. Ther Adv Musculoskelet Dis. https:\/\/doi.org\/10.1177\/1759720X221122417\/ASSET\/IMAGES\/LARGE\/10.1177_1759720X221122417-FIG1.JPEG","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"5536_CR42","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1136\/ARD.2006.056457","volume":"66","author":"SJ Bond","year":"2007","unstructured":"Bond SJ, Farewell VT, Schentag CT, Gladman DD (2007) Predictors for radiological damage in psoriatic arthritis: results from a single centre. Ann Rheum Dis 66:370. https:\/\/doi.org\/10.1136\/ARD.2006.056457","journal-title":"Ann Rheum Dis"},{"key":"5536_CR43","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/S40744-018-0120-8","volume":"5","author":"K de Vlam","year":"2018","unstructured":"de Vlam K, Merola JF, Birt JA et al (2018) Skin involvement in psoriatic arthritis worsens overall disease activity, patient-reported outcomes, and increases healthcare resource utilization: an observational. Cross-Sect Study Rheumatol Ther 5:423. https:\/\/doi.org\/10.1007\/S40744-018-0120-8","journal-title":"Cross-Sect Study Rheumatol Ther"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-024-05536-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00296-024-05536-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-024-05536-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,8]],"date-time":"2024-03-08T21:37:17Z","timestamp":1709933837000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00296-024-05536-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,6]]},"references-count":43,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2024,4]]}},"alternative-id":["5536"],"URL":"https:\/\/doi.org\/10.1007\/s00296-024-05536-1","relation":{},"ISSN":["1437-160X"],"issn-type":[{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,6]]},"assertion":[{"value":"20 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"GH is the founder and previous shareholder in the company manufacturing the GoTreatIt Rheuma tool. BM has received consultant fees from Novartis and research grant from Novartis (paid to the employer). MW, K\u0141, AK, and MK have declared no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"Written informed consent was obtained from all individual participants included in the study. Data in the study were anonymized.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants and\/or animals"}}]}}